Want to see BCLI full AI Analyst Report?
Brainstorm Cell Therapeutics (BCLI) Ownership - Who Owns Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics (BCLI) Ownership Overview
- 28.36% Insiders
- 0.03% Mutual Funds
- 1.32% Other Institutional Investors
- 70.29% Public Companies and Individual Investors
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 1.35% of the company’s stock is owned by Institutional Investors, 28.36% is owned by Insiders, and 70.29% is owned by Public Companies and Individual Investors.
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 1.35% of the company’s stock is owned by Institutional Investors, 28.36% is owned by Insiders, and 70.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Chaim Lebovits | 2,000,960 | Insider | 18.13% | 1,720,826 |
| Jacob Frenkel | 343,777 | Insider | 3.12% | 295,648 |
| Uri Yablonka | 218,464 | Insider | 1.98% | 187,879 |
| Irit Arbel | 161,054 | Insider | 1.46% | 138,506 |
| Alla Patlis | 144,349 | Insider | 1.31% | 124,140 |
| Ibrahim B. Dagher | 79,515 | Insider | 0.72% | 68,383 |
| Hartoun Hartounian | 52,000 | Insider | 0.47% | 44,720 |
| Stacy Lindborg | 48,229 | Insider | 0.44% | 41,477 |
| Nir Naor | 31,465 | Insider | 0.29% | 27,060 |
| Anthony J. Polverino | 25,730 | Insider | 0.23% | 22,128 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Victory Portfolios Iii | 3,152 | Institution | 0.03% | 2,711 |
FAQ
Who Owns Brainstorm Cell Therapeutics (BCLI)?
According to the latest TipRanks data, approximately 1.35% of the company's stock is held by institutional investors, 28.36% is held by insiders, and 70.29% is held by public companies and individual investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.35% of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors: 0.03% by mutual funds and 1.32% by other institutional investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors?
According to the latest TipRanks data, approximately 70.29% of Brainstorm Cell Therapeutics (BCLI) stock is held by public companies and individual investors.
Who owns the most shares of Brainstorm Cell Therapeutics (BCLI)?
Chaim Lebovits owns the most shares of Brainstorm Cell Therapeutics (BCLI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
